§ 109051

For purposes of this chapter, the following terms have the following definitions:

(a) “DEHP” means Di(2-ethylhexyl) phthalate.

(b) “Intentionally added DEHP” means DEHP that a manufacturer has intentionally added to an intravenous solution container or intravenous tubing product that has a functional or technical effect on the product.

(c) “Intravenous solution containers” means a container used to house medicine, fluid, or nutrition therapy that is intravenously administered to patients in a hospital, outpatient, or other health care facility.

(d) “Intravenous tubing” means any tubing used to intravenously administer fluids, medication, or nutrients directly to an adult, child, or infant.

(e) “Ortho-phthalates” means a class of chemicals that are esters of ortho-phthalic acid, including all of the following:

(1) Benzyl-butyl phthalate (BBP) 85-68-7.

(2) Dibutyl phthalate (DBP) 84-74-2.

(3) Dicyclohexyl phthalate (DCHP) 84-61-7.

(4) Di-(2-ethylhexyl) phthalate (DEHP) 117-81-7.

(5) Diethyl phthalate (DEP) 84-66-2.

(6) Di-isobutyl phthalate (DIBP) 84-69-5.

(7) Di-isodecyl phthalate (DIDP) 26761-40-0.

(8) Di-isononyl phthalate (DINP) 28553-12-0.

(9) Di-n-hexyl phthalate (DnHP) 84-75-3.

(10) Di-n-octyl phthalate (DNOP) 117-84-0.

(11) Di-n-pentyl (DnPP) phthalate 131-18-0.

(12) Diisoheptyl phthalate (DIHP) 71888-89-6.

(f) “Unintentionally added DEHP” means DEHP in an intravenous solution container or intravenous tubing product that is not used for functional or technical effect on the product.

(Added by Stats. 2024, Ch. 562, Sec. 1. (AB 2300) Effective January 1, 2025.)